Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 3,779,000 | 3,927,000 | 3,866,000 | 3,330,000 | 3,114,000 |
| Cost of Goods | 476,000 | 546,000 | 489,000 | 474,000 | 586,000 |
| Gross Profit | 3,303,000 | 3,381,000 | 2,753,000 | 2,856,000 | 3,047,000 |
| Operating Expenses | 2,232,000 | 2,225,000 | 2,063,000 | 1,873,000 | 2,074,000 |
| Operating Income | 1,071,000 | 1,156,000 | 1,314,000 | 983,000 | 454,000 |
| Other Income | -43,000 | -7,000 | -1,284,000 | -281,000 | 446,000 |
| Pre-tax Income | 1,028,000 | 1,149,000 | 30,000 | 702,000 | 900,000 |
| Income Tax | 298,000 | 333,000 | -84,000 | 186,000 | 271,000 |
| Net Income Continuous | 729,000 | 815,000 | 383,000 | 515,000 | 594,000 |
| Net Income Discontinuous | -20,000 | 0 | 328,000 | 882,000 | 34,000 |
| Net Income | $709,000 | $815,000 | $711,000 | $1,397,000 | $628,000 |
| EPS Basic Total Ops | 0.18 | 0.22 | 0.17 | 0.37 | 0.17 |
| EPS Basic Continuous Ops | 0.19 | 0.22 | 0.10 | 0.14 | 0.16 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | 0.09 | 0.23 | 0.01 |
| EPS Diluted Total Ops | 0.18 | 0.21 | 0.18 | 0.37 | 0.17 |
| EPS Diluted Continuous Ops | 0.19 | 0.21 | 0.10 | 0.14 | 0.16 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | 0.08 | 0.23 | 0.01 |
| EBITDA(a) | $1,187,000 | $1,284,000 | $1,359,000 | $1,159,000 | $588,000 |